Valuation: HemaCare Corporation

Market Cap 35Cr 31Cr 29Cr 26Cr 49Cr 3.32TCr 50Cr 346.93Cr 134.44Cr 1.7TCr 129.79Cr 126.98Cr 5.45TCr P/E 2017
8.18x
P/E 2018 27.6x
Enterprise Value 34Cr 30Cr 28Cr 25Cr 48Cr 3.23TCr 48Cr 337Cr 130.59Cr 1.65TCr 126.08Cr 123.34Cr 5.3TCr EV / Sales 2017
1.29x
EV / Sales 2018 4.03x
Free-Float
94.17%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Operating Officer - 01/01/2003
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.08% - - 35Cr
+1.48%-3.00%+11.63%+24.06% 11TCr
+0.78%-2.05%0.00%+72.60% 9.24TCr
+0.46%-0.54%+156.13%+839.45% 5.91TCr
-0.38%-5.45%-7.18%+53.64% 2.77TCr
+0.97%-1.27%+28.94%+92.98% 2.58TCr
+1.28%-0.37%+10.40%+54.59% 2.5TCr
-0.57%+0.09%-15.78%-7.70% 2.1TCr
+1.83%-0.42%+27.16%+290.84% 2.08TCr
+1.30%-2.86%-5.57%+34.95% 1.69TCr
Average +0.72%-1.64%+22.86%+161.71% 4TCr
Weighted average by Cap. +0.89%-2.05%+28.73%+177.21%

Financials

2017 2018
Net sales 2.02Cr 1.8Cr 1.68Cr 1.53Cr 2.88Cr 194.3Cr 2.91Cr 20Cr 7.86Cr 99Cr 7.59Cr 7.42Cr 318.79Cr 2.85Cr 2.53Cr 2.36Cr 2.15Cr 4.06Cr 274.04Cr 4.1Cr 29Cr 11Cr 140.09Cr 11Cr 10Cr 449.6Cr
Net income 44.32L 39.38L 36.75L 33.5L 63.18L 43Cr 63.77L 4.45Cr 1.72Cr 22Cr 1.66Cr 1.63Cr 70Cr 45.16L 40.12L 37.45L 34.13L 64.38L 43Cr 64.98L 4.53Cr 1.76Cr 22Cr 1.7Cr 1.66Cr 71Cr
Net Debt -90.59L -80.49L -75.12L -68.47L -1.29Cr -87Cr -1.3Cr -9.09Cr -3.52Cr -45Cr -3.4Cr -3.33Cr -142.88Cr -98.97L -87.93L -82.07L -74.81L -1.41Cr -95Cr -1.42Cr -9.93Cr -3.85Cr -49Cr -3.72Cr -3.64Cr -156.1Cr
Logo HemaCare Corporation
Charles River Laboratories Cell Solutions, Inc. is a cell sourcing provider for developers of cell therapies and basic research. The Company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. It offers a comprehensive and integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Its products and services include Research Models & Services, Discovery Services Safety Assessment, Laboratory Sciences, Cell and Gene Therapy CDMO Solutions, Biologics Testing Solutions, Avian Vaccine Services, QC Microbial Solutions, Scientific & Regulatory Advisory Services, and Scientific Staffing, Training & Operations Support.
Employees
-
  1. Stock Market
  2. Stocks
  3. HEMA Stock